Krka’s well-established broad-spectrum dog and cat-wormer, Milprazon, has been further upgraded to a new highly palatable format to facilitate easier year-round worming regimes for dogs and cats.
Milprazon Chewable is the first wormer in its category with proven palatability for dogs based on EMA Testing Guidelines. In a study, more than 85 percent of dogs ate the tablet “voluntarily”, with 75 percent taking it unprompted from their food bowl.
The optimised tablet shape across the range combines the best features of both chewable and film-coated tablets and the new colour-coded packaging supports clear and simple dispensing.
Milprazon Chewable is the latest addition to Krka’s portfolio of added value, tried and trusted generic medicines and is available in a range of presentations, making it suitable for puppies from two weeks old (0.5 kilogram) and kittens from six weeks old.
Commenting on its launch, Krka’s National Sales Manager Will Ridgway, said: “Milprazon Chewable is a premium product. It offers pet owners the reliability of Milbemycin oxime and Praziquantel, together with enhanced palatability, while supporting practice profitability.
“Even more so given the increase in numbers of dogs and cats as a result of the pandemic, supporting owners in complying with appropriate year-round worming regimes is a priority for Krka and for the veterinary practices we serve.
“The addition of Milprazon Chewable strengthens our worming range and ensures that Krka continues to offer comprehensive, reliable and affordable parasite control solutions using the latest formulation technology.”
